Localized deferoxamine injection augments vascularity and improves bony union in pathologic fracture healing after radiotherapy

Bone

Volumn 52, Issue 1, 2013, Pages 318-325

  Donneys, Alexis ^a   Weiss, Daniela M ^a   Deshpande, Sagar S ^a   Ahsan, Salman ^a   Tchanque Fossuo, Catherine N ^a   Sarhaddi, Deniz ^a   Levi, Benjamin ^a   Goldstein, Steven A ^a   Buchman, Steven R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Angiogenesis; Deferoxamine; Non union; Osteoradionecrosis; Pathologic fracture; Radiotherapy

Indexed keywords

DEFEROXAMINE; GENTAMICIN; IRON CHELATING AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALLUS; CONTROLLED STUDY; DRUG MEGADOSE; EXTERNAL FIXATOR; FRACTURE HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; LONG BONE; LOW DRUG DOSE; MALE; MANDIBLE FRACTURE; MANDIBLE OSTEOTOMY; NONHUMAN; PATHOLOGIC FRACTURE; PSEUDARTHROSIS; RADIATION; RADIOTHERAPY; RAT; VASCULARIZATION;

ANIMALS; CELLS, CULTURED; DEFEROXAMINE; FRACTURE HEALING; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RADIOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84868591772     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.10.014     Document Type: Article

References (27)

1. Grandis J.R., Pietenpol J.A., Greenberger J.S., et al. Head and neck cancer. Cancer Res 2004, 64:8126.
2. Dimery W., Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993, 85(2):95-111.
3. Nakamizo M., Yokoshima K., Yagi T. Use of free flaps for reconstruction in head and neck surgery: a retrospective study of 182 cases. Auris Nasus Larynx 2004, 31:269-273.
4. Ross D.A., Hundal J.S., Son Y.H., et al. Microsurgical free flap reconstruction outcomes in head and neck cancer patients after surgical extirpation and intraoperative brachytherapy. Laryngoscope 2004, 114:1170-1176.
5. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res 1998, 355(Suppl.):S82-S89.
6. Xie X.T., Qiu W.L., Yuan W.H., Wang Z.H. Experimental study of radiation effect on the mandibular microvasculature of the guinea pig. Chin J Dent Res 1998, 1(2):46-51.
7. Cao X., Wu X., Frassica D., et al. Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. Proc Natl Acad Sci U S A 2011, 108(4):1609-1614.
8. Deshpande S.S., Donneys A., Farberg A.S., Tchanque-Fossuo C.N., Zehtabzadeh A.J., Buchman S.R. Quantification and characterization of radiation-induced changes to mandibular vascularity using micro-computed tomography. Plast Reconstr Surg 2010, 125(6):40.
9. Brittenham G.M. Iron-chelating therapy for transfusional iron overload. N Engl J Med 2011, 364:146-156.
10. Shen X., Wan C., Ramaswamy G., et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 2009, 27(10):1298-1305.
11. Wan C., Gilbert S.R., Cao X., et al. Activation of the hypoxia-inducible factor-1HIF 1-α pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 2008, 105:686-691.
12. Street J., Bao M., DeGuzman L., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002, 99:9656-9661.
13. Gevorgyan A., La Scala G.C., Sukhu B., et al. An in vitro model of radiation-induced craniofacial bone growth inhibition. J Craniofac Surg 2007, 18:1044-1050.
14. Levi B., Nelson E., Hyun J., et al. Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg 2012, 129:53-66.
15. Monson L.A., Farberg A.S., Jing X.L., Buchman S.R. Human equivalent radiation dose response in the rat mandible. Plast Reconstr Surg 2009, 124(4S):2.
16. Tchanque-Fossuo C.N., Monson L.A., Farberg A.S., Donneys A., Deshpande S.S., Razdolsky E.R., et al. Dose-response effect of human equivalent radiation in the murine mandible. Plast Reconstr Surg 2011, 128(5):480e-487e.
17. Buchman S.R., Ignelzi M.A., Radu C., et al. A unique rodent model of distraction osteogenesis of the mandible. Ann Plast Surg 2002, 49:511-519.
18. Farberg A.S., Jing X.L., Monson L.A., Donneys A., Tchanque-Fossuo C.N., Deshpande S.S., et al. Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandible. Bone 2012, 50(5):1184-1187.
19. Donneys A., Farberg A.S., Tchanque-Fossuo C.N., Deshpande S.S., Buchman S.R. Deferoxamine enhances the vascular response of bone regeneration in mandibular distraction osteogenesis. Plast Reconstr Surg 2012, 129(4):850-856.
20. Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res 1994, 301:124-131.
21. AI-Aql Z.S., Alagl A.S., Graves D.T., et al. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87(2):107-118.
22. Bouxsein M.L., Boyd S.K., Christiansen B.A., et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
23. Duvall C.L., Taylor W.R., Weiss D., Guldberg R.E. Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 2004, 287(1):302-310.
24. Blatt J., Taylor S.R., Stitely S. Mechanism of antineuroblastoma activity of deferoxamine in vitro. J Lab Clin Med 1988, 112:433.
25. Hann H.W.L., Stahlhut M.W., Rubin R., Maddrey W.C. Antitumor effect of deferoxamine in human hepatocellular carcinoma growing in athymic nude mice. Cancer 1992, 70:2051.
26. Donfrancesco A., Deb G., Dominici C., et al. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res 1990, 50:4929-4930.
27. Kulp K.S., Vulliet P.R. Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. Toxicol Appl Pharmacol 1996, 139:356-364.